Oncternal Therapeutics (ONCT)
(Delayed Data from NSDQ)
$4.95 USD
+0.10 (2.04%)
Updated Aug 23, 2024 03:48 PM ET
2-Buy of 5 2
F Value C Growth F Momentum F VGM
Earnings News For ONCT
-
Oncternal Therapeutics (ONCT) Reports Q2 Loss, Tops Revenue Estimates
-
Oncternal Therapeutics: Q2 Earnings Snapshot
-
Oncternal Therapeutics (ONCT) Reports Q1 Loss, Tops Revenue Estimates
-
Oncternal Therapeutics: Q1 Earnings Snapshot
-
Oncternal Therapeutics (ONCT) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
-
Oncternal Therapeutics: Q4 Earnings Snapshot
-
Oncternal Therapeutics (ONCT) Reports Q4 Loss, Tops Revenue Estimates
-
Oncternal Therapeutics: Q3 Earnings Snapshot
-
Oncternal Therapeutics (ONCT) Reports Q2 Loss, Lags Revenue Estimates
-
Oncternal Therapeutics: Q2 Earnings Snapshot
-
Oncternal Therapeutics (ONCT) Reports Q1 Loss, Tops Revenue Estimates
-
Oncternal Therapeutics: Q1 Earnings Snapshot
-
Oncternal Therapeutics (ONCT) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
-
Oncternal Therapeutics: Q4 Earnings Snapshot
-
Oncternal Therapeutics (ONCT) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release
-
Oncternal Therapeutics (ONCT) Reports Q3 Loss, Misses Revenue Estimates
-
Oncternal Therapeutics: Q3 Earnings Snapshot
-
Oncternal Therapeutics (ONCT) Reports Q2 Loss, Lags Revenue Estimates
-
Oncternal Therapeutics: Q2 Earnings Snapshot
-
Oncternal Therapeutics (ONCT) Reports Q1 Loss, Tops Revenue Estimates
-
Oncternal Therapeutics (ONCT) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
-
Oncternal Therapeutics (ONCT) Reports Q4 Loss, Lags Revenue Estimates
-
Oncternal Therapeutics (ONCT) Reports Q3 Loss, Tops Revenue Estimates
-
Will Oncternal Therapeutics (ONCT) Report Negative Q3 Earnings? What You Should Know
-
Oncternal Therapeutics (ONCT) Reports Q2 Loss, Lags Revenue Estimates